4/A: Cue Biopharma Director Receives Stock Grant
Insider Transaction (Form 4/A)
Pasha Sarraf, a Director of Cue Biopharma, Inc., received 18,400 shares of common stock on July 9, 2026.
Summary
- Grant/award: acquired 18,400 Common Stock on July 9, 2026; holds 29,195 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Pasha Sarraf — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-09 | Grant/award | Common Stock | 18,400 | — | — | 29,195 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-09 | Grant/award (18,400 shares) |
Keywords
insider transaction, Form 4/A, CUE, Cue Biopharma, Inc., neutral, Pasha Sarraf
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.